SP Globals Mobility SpinOff A Strategic Move for Shareholder Value and Dividend Growth Oil Prices Climb as Iran Establishes New Uranium Enrichment Red Lines Grenfell Tower Prosecutions Charges Recommended Against 77 Individuals and Organisations After NineYear Investigation SpaceX Postpones Starship Launch Amid Plans for RecordBreaking Stock Market Debut Sindhu Trade Links Shares Rise After Board Approves Acquisitions and Capital Hike Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Demand Landscape KMI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency KD Q1 2026 Earnings EPS Miss Overshadowed by Strategic Optimism NG Q1 2026 Earnings EPS Beat Amid Ongoing Development Progress DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction FNWD Q1 2026 Earnings EPS Miss Slightly as Stock Nudges Higher LGND Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Strength STMicroelectronics STM Rises 17 as Traders Eye Key Resistance Aviat Networks AVNW Holds Near Support as Trading Range Narrows Titan Machinery TITN Holds Steady Near Support as Agricultural Sector Awaits Catalysts Hongli Group Inc HLP Shares Edge Lower Testing Key Support Near 044 Western Asset Bond Fund WEA Edges Higher as FixedIncome Investors Assess Rate Outlook Trump Invests Up to 5 Million in Boeing Stock Ahead of Reported China Deal CNP Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Edges Higher Procter Gamble PG Edges Higher Resilience in a Shifting Consumer Landscape GSAT Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Investment Period Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS VYX Q1 2026 Earnings EPS Surpasses Estimates by 212 Shares Edge Higher CGBD Q1 2026 Earnings Narrow EPS Miss Amid Stable Credit Performance IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up